SCHEMBL23488462

SCHEMBL23488462

CO[C@@H]1O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H]2OC(C)(C)O[C@@H]2[C@H]1OC(=O)c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
NT5E P21589 1/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
ADRB3 P13945 1/20 0.38
PTPN1 P18031 9/20 0.38
HIF1A Q16665 1/20 0.37
PTPN2 P17706 2/20 0.36
PTPN6 P29350 2/20 0.36
PTPN11 Q06124 2/20 0.36
MAOB P27338 1/20 0.36
PPARG P37231 1/20 0.36
CHRNB2 P17787 1/20 0.35
CHRNA5 P30532 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35
NR4A1 P22736 1/20 0.35
NR4A2 P43354 1/20 0.35
NR4A3 Q92570 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488116 0.86 ADRB2 (0.41) NT5EADRB2ADRB1ADRB3PTPN1
SCHEMBL15953011 0.79 ALDH1A1 (0.47) ALDH1A1NT5EPTPN1CYP3A4
SCHEMBL23488672 0.78 ALDH1A1 (0.54) ALDH1A1ADRB2ADRB1ADRB3HIF1A
SCHEMBL23488461 0.78 ALDH1A1 (0.54) ALDH1A1ADRB2ADRB1ADRB3HIF1A
SCHEMBL22490847 0.76 ALDH1A1 (0.54) ALDH1A1ADRB2ADRB1ADRB3HIF1A
SCHEMBL22490882 0.76 ALDH1A1 (0.54) ALDH1A1ADRB2ADRB1ADRB3HIF1A
SCHEMBL22490892 0.75 ADRB2 (0.39) ALDH1A1NT5EADRB2ADRB1ADRB3
SCHEMBL6758122 0.74 SSTR1 (0.42) ALDH1A1NT5EPTPN1PTPN2CYP3A4
SCHEMBL6806216 0.73 ALDH1A1 (0.38) ALDH1A1CYP3A4
SCHEMBL8815770 0.73 ALDH1A1 (0.56) ALDH1A1ADRB2ADRB1ADRB3HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 ALDH1A1 1627/4885NT5E 2310/4885ADRB2 2675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.